CAS, a division of the American Chemical Society specializing in scientific information solutions, has announced the launch of a major expansion of the CAS SciFinder Discovery Platform into life sciences. The enhanced platform includes over 2 million modified biosequences, 60 years of patent literature, and one of the largest collections of journal information including PubMed’s biomedical and life science data.
The CAS SciFinder Discovery Platform expansion unlocks human-indexed insights from journals and patents in over 50 languages dating back to 1957 and 70 million biosequences curated by CAS scientists. The collection also includes unique biosequences not found elsewhere in electronic resources.
The launch is the culmination of an 18-month effort to curate over 600 million additional proteins and nucleotides and integrate BLAST (Basic Local Alignment Search Tool), CDR (Complementarity-Determining Regions) for antibody and T-cell receptors, and motif search capabilities into the platform.
CAS SciFinder Discovery Platform leverages the largest curated source of scientific information in the world, uniting task-specific solutions including CAS SciFindern, CAS Formulus®, and CAS Analytical Methods™. The CAS SciFinder Discovery Platform supports multifaceted scientific research such as retrosynthetic planning, formulation design, testing-related methods research, and biosequence searching to accelerate breakthroughs at every step of the innovation journey.
Click here to read the original press release.
